INSTITUTE EUROPHARM, s.r.o.

Active
IČO 36807427limited liability company (s.r.o.)Founded 2007Kežmarok

Key figures

1 868 390 €+177,0%
Revenue 2025
+10,1%
Average annual growth 2020–2025
0500 k1 m1,5 m2 m202020212022202320242025

Key figures

2025

Summary: INSTITUTE EUROPHARM, s.r.o.

What kind of company is it?

INSTITUTE EUROPHARM, s.r.o. (IČO 36807427) is a limited liability company (s.r.o.). The company was incorporated in 2007 and has existed for 19 years. Registered office according to the register: Kežmarok. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 10–19 employees.

Who runs the company and who owns it?

The company has one statutory representative. According to the register, the company has 8 shareholders. The registered capital is 2 100 000 €.

How is the company doing financially?

Revenue for 2025 was 1 868 390 €, up 177 % on the previous year (674 518 €). From 2020 to 2025, revenue grew by an average of 10,1 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 217 808 € (11,7 % of revenue). The company was profitable in 1 of the 6 reported years. Personnel costs for 2025 were 547 282 €. At the end of 2025 the company had total assets of 9 390 944 € and equity of 1 169 981 € (equity ratio 12,5 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. The LEI code (315700F8MUDMZ1ZDFE95) comes from the GLEIF database. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)1 548 455883 3871 156 097674 5181 868 390
Profit for the reporting year-1 115 096-845 734-620 188-1 076 799217 808
Retained earnings of previous periods-12 442 473-13 557 569-14 403 303-15 023 492-16 100 291
Total assets10 028 1729 491 7579 597 9119 243 0129 390 944
Total liabilities8 983 2778 492 5968 518 9388 290 8398 220 963
Total equity1 044 895999 1611 078 973952 1731 169 981
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a company to see its connections.

15 %14,5 %14 %14 %11,5 %11 %director20 %INSTITUTEEUROPHARM, s.r.o.INSTITUTE EUROPHARM, s.r.o.EKElli KaplinaElli KaplinaVKValeriy KaplinValeriy KaplinMKMarina KaplinaMarina KaplinaTKTatiana KaplinaTatiana KaplinaALAlexander LadyginAlexander LadyginALAlexandra LadyginaAlexandra LadyginaMLIng. Marian LuknišIng. Marian Lukniš⋯2 smallershareholders+2 smaller shareholders
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements14

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same address
Same industry (SK NACE 2120)
INSTITUTE EUROPHARM, s.r.o. (IČO 36807427) – revenue 1,9M €